Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rosalind Advisors, Inc.(1.34%),Steven Salamon(1.34%), etc.
Apr 25 19:41 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simon Farrell
Feb 16 16:48 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Galletta Christopher
Feb 16 16:48 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clark David J
Feb 16 16:47 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOOD JENNIFER L
Feb 16 16:47 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SCIASCIA THOMAS
Feb 16 16:47 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Delfini Lisa
Feb 16 16:47 ET
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%), etc.
Feb 14 20:48 ET
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(0.0%),Peter Harwin(0.0%), etc.
Feb 14 15:55 ET
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(9.99%),Viking Global Opportunities Parent GP LLC(9.99%), etc.
Feb 14 10:27 ET
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(8.90%),David Rosen(8.90%)
Feb 12 07:07 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Delfini Lisa
Oct 12, 2023 16:00 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Delfini Lisa
Sep 13, 2023 16:06 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Delfini Lisa
Aug 14, 2023 16:00 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Delfini Lisa
Jul 12, 2023 16:29 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mathers Edward T
Jun 30, 2023 16:14 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cassella James V
Jun 30, 2023 16:00 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heffernan Michael Thomas
Jun 30, 2023 16:00 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Meeker David P
Jun 30, 2023 16:00 ET
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Colangelo Dominick
Jun 30, 2023 16:00 ET
No Data
No Data